Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells
- 15 July 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (2), 651-660
- https://doi.org/10.1182/blood-2006-08-042630
Abstract
Nbs1, a member of the Mre11-RAD50-Nbs1 complex, is phosphorylated by ATM, the product of the ataxia-telangiectasia mutated gene and a member of the phosphatidylinositol 3-kinase–related family of serine-threonine kinases, in response to DNA double-strand breaks (DSBs) to regulate DNA damage checkpoints. Here we show that BCR/ABL stimulated Nbs1 expression by induction of c-Myc–dependent transactivation and protection from caspase-dependent degradation. BCR/ABL-related fusion tyrosine kinases (FTKs) such as TEL/JAK2, TEL/PDGFβR, TEL/ABL, TEL/TRKC, BCR/FGFR1, and NPM/ALK as well as interleukin 3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and stem cell factor (SCF) also stimulated Nbs1 expression. Enhanced ATM kinase–dependent phosphorylation of Nbs1 on serine 343 (S343) in response to genotoxic treatment was detected in leukemia cells expressing BCR/ABL and other FTKs in comparison to normal counterparts stimulated with IL-3, GM-CSF, and SCF. Expression of Nbs1-S343A mutant disrupted the intra–S-phase checkpoint, decreased homologous recombinational repair (HRR) activity, down-regulated XIAP expression, and sensitized BCR/ABL-positive cells to cytotoxic drugs. Interestingly, inhibition of Nbs1 phosphorylation by S343A mutant enhanced the antileukemia effect of the combination of imatinib and genotoxic agent.Keywords
This publication has 77 references indexed in Scilit:
- Conditional deletion of Nbs1 in murine cells reveals its role in branching repair pathways of DNA double-strand breaksThe EMBO Journal, 2006
- The role of NBS1 in DNA double strand break repair, telomere stability, and cell cycle checkpoint controlCell Research, 2006
- DNA Lesion-specific Co-localization of the Mre11/Rad50/Nbs1 (MRN) Complex and Replication Protein A (RPA) to Repair FociPublished by Elsevier BV ,2005
- NBS1 Expression as a Prognostic Marker in Uveal MelanomaClinical Cancer Research, 2005
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- Interaction of FANCD2 and NBS1 in the DNA damage responseNature, 2002
- The DNA damage-dependent intra–S phase checkpoint is regulated by parallel pathwaysNature Genetics, 2002
- Chk2 Activation Dependence on Nbs1 after DNA DamageMolecular and Cellular Biology, 2001
- Evolution of bone marrow transplantation – the original immunotherapyTrends in Immunology, 2001